Filing Details

Accession Number:
0001179110-21-008415
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-25 16:37:50
Reporting Period:
2021-08-23
Accepted Time:
2021-08-25 16:37:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286370 R Michael Minogue C/o Abiomed, Inc.,
22 Cherry Hill Drive
Danvers MA 01923
Chairman, President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2021-08-23 3,492 $23.15 215,127 No 4 M Direct
Common Stock $.01 Par Value Disposition 2021-08-23 3,492 $350.00 211,635 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-08-23 3,492 $0.00 3,492 $23.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-14 2023-05-14 No 4 D Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock $.01 Par Value 52,555 Indirect By Trust - A
Common Stock $.01 Par Value 73,745 Indirect By Trust - B
Common Stock $.01 Par Value 32,810 Indirect By Trust - C
Common Stock $.01 Par Value 655 Indirect By Trust - D
Common Stock $.01 Par Value 38,560 Indirect By Trust - E
Common Stock $.01 Par Value 85,040 Indirect By Trust - F
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $21.55 2015-05-14 2024-05-14 0 85,000 Direct
Common Stock Stock Option (right to buy) $66.25 2016-05-13 2025-05-13 0 35,000 Direct
Common Stock Stock Option (right to buy) $99.62 2017-05-24 2026-05-24 0 30,500 Direct
Common Stock Stock Option (right to buy) $134.51 2018-05-15 2027-05-15 0 33,000 Direct
Common Stock Stock Option (right to buy) $381.97 2019-05-16 2028-05-16 0 30,000 Direct
Common Stock Stock Option (right to buy) $266.39 2020-05-30 2029-05-30 0 50,000 Direct
Common Stock Stock Option (Right to Buy) $223.90 2021-05-29 2030-05-29 0 20,898 Direct
Common Stock Stock Option (Right to Buy) $283.88 2022-05-25 2031-05-25 0 30,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-05-14 0 85,000 Direct
2025-05-13 0 35,000 Direct
2026-05-24 0 30,500 Direct
2027-05-15 0 33,000 Direct
2028-05-16 0 30,000 Direct
2029-05-30 0 50,000 Direct
2030-05-29 0 20,898 Direct
2031-05-25 0 30,000 Direct
Footnotes
  1. These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
  2. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  3. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  4. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  5. Exercise of stock options pursuant to reporting owners 10b5-1 plan.
  6. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  7. This price represents the sale price of the transactions on the reported date at $350.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.